Holen Sie sich die Stockscreener-App
86.81
0.95%
0.83
Schlusskurs vom Vortag:
$85.98
Offen:
$85.92
24-Stunden-Volumen:
555.00K
Relative Volume:
0.30
Marktkapitalisierung:
$16.95B
Einnahmen:
$4.58B
Nettoeinkommen (Verlust:
$870.87M
KGV:
19.73
EPS:
4.4
Netto-Cashflow:
$945.58M
1W Leistung:
+2.30%
1M Leistung:
+14.82%
6M Leistung:
+23.53%
1J Leistung:
+30.89%
1-Tages-Spanne:
$85.72
$87.46
1-Wochen-Bereich:
$83.41
$87.99
52-Wochen-Spanne:
$53.56
$87.99
Incyte Corp Stock (INCY) Company Profile
Firmenname
Incyte Corp
Sektor
Branche
Telefon
(302) 498-6700
Adresse
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE
Vergleichen Sie INCY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INCY
Incyte Corp
|
86.81 | 16.52B | 4.58B | 870.87M | 945.58M | 4.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.60 | 100.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.02 | 61.55B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.79 | 58.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.76 | 43.59B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
337.66 | 33.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Incyte Corp Stock (INCY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-08-01 | Eingeleitet | Barclays | Overweight |
| 2025-06-16 | Hochstufung | Stifel | Hold → Buy |
| 2025-03-18 | Herabstufung | Guggenheim | Buy → Neutral |
| 2025-03-18 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-12-17 | Eingeleitet | UBS | Neutral |
| 2024-10-29 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-01 | Eingeleitet | Wolfe Research | Outperform |
| 2024-09-18 | Herabstufung | Truist | Buy → Hold |
| 2024-07-02 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2024-05-23 | Eingeleitet | Deutsche Bank | Hold |
| 2024-04-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2024-02-23 | Eingeleitet | Jefferies | Buy |
| 2024-02-14 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2023-12-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2023-12-04 | Hochstufung | Guggenheim | Neutral → Buy |
| 2023-11-21 | Herabstufung | Goldman | Buy → Neutral |
| 2023-07-25 | Eingeleitet | Citigroup | Buy |
| 2023-05-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-04-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-03-24 | Hochstufung | SVB Securities | Underperform → Market Perform |
| 2023-01-31 | Eingeleitet | Piper Sandler | Overweight |
| 2022-08-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-08-03 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-07-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-02-09 | Herabstufung | SVB Leerink | Mkt Perform → Underperform |
| 2022-01-18 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-07-20 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2021-02-10 | Herabstufung | SVB Leerink | Mkt Perform → Underperform |
| 2021-01-07 | Eingeleitet | Truist | Buy |
| 2021-01-04 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-06-16 | Eingeleitet | The Benchmark Company | Hold |
| 2020-05-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-04-29 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-04-01 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-03-24 | Fortgesetzt | William Blair | Outperform |
| 2020-03-13 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-04 | Fortgesetzt | BofA/Merrill | Neutral |
| 2020-01-03 | Bestätigt | BMO Capital Markets | Market Perform |
| 2020-01-03 | Herabstufung | Mizuho | Buy → Neutral |
| 2020-01-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-10-03 | Eingeleitet | Mizuho | Buy |
| 2019-09-12 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2019-09-05 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-09-05 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-09-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2019-05-21 | Eingeleitet | Credit Suisse | Neutral |
| 2019-05-03 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-04-11 | Eingeleitet | Stifel | Hold |
| 2019-04-03 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-01-24 | Hochstufung | William Blair | Mkt Perform → Outperform |
Alle ansehen
Incyte Corp Aktie (INCY) Neueste Nachrichten
Combining price and volume data for Incyte CorporationRecession Risk & Accurate Buy Signal Notifications - Newser
Incyte at Cantor Global Healthcare Conference: Strategic Growth Beyond 2029 - Investing.com
Incyte launches educational campaign to raise awareness of HS - Investing.com
Incyte Launches HS TRUTHS to Spotlight the True Lived Experience of Hidradenitis Suppurativa - Financial Times
Should you wait for a breakout in Incyte CorporationShare Buyback & Scalable Portfolio Growth Ideas - Newser
Should I invest in Incyte Corporation before earnings2025 Historical Comparison & High Return Stock Watch Alerts - khodrobank.com
Quantitative breakdown of Incyte Corporation recent moveTreasury Yields & Daily Chart Pattern Signal Reports - Newser
Can trapped investors hope for a rebound in Incyte CorporationIPO Watch & Weekly Top Stock Performers List - Newser
What Fibonacci levels say about Incyte Corporation rebound2025 Big Picture & Long-Term Growth Stock Strategies - Newser
Incyte (INCY) Stock Is Up, What You Need To Know - Yahoo Finance
Advanced analytics toolkit walkthrough for Incyte CorporationJuly 2025 WrapUp & Verified Chart Pattern Signals - Newser
Applying Elliott Wave Theory to Incyte CorporationAnalyst Upgrade & Smart Allocation Stock Tips - Newser
Incyte Corporation stock hits 52-week high at 87.27 USD - Investing.com
What’s the recovery path for long term holders of Incyte CorporationJuly 2025 Opening Moves & Technical Pattern Alert System - Newser
Reversal indicators forming on Incyte Corporation stockWeekly Market Outlook & Intraday High Probability Setup Alerts - Newser
Can Incyte Corporation disrupt its industry2025 Short Interest & Safe Capital Growth Tips - khodrobank.com
What institutional flow reveals about Incyte CorporationJuly 2025 Big Picture & Trade Opportunity Analysis - Newser
What candlestick patterns are forming on Incyte Corporation2025 Historical Comparison & Fast Gain Stock Trading Tips - Newser
How sentiment analysis helps forecast Incyte CorporationBull Run & Fast Exit/Entry Strategy Plans - Newser
What indicators show strength in Incyte Corporation2025 Volume Leaders & Real-Time Volume Analysis - Newser
Long term hold vs stop loss in Incyte CorporationJuly 2025 Catalysts & Weekly Setup with ROI Potential - Newser
Will Incyte Corporation stock recover after recent drop2025 Trade Ideas & Fast Gain Swing Alerts - Newser
Using portfolio simulators with Incyte Corporation includedTrade Signal Summary & Technical Pattern Alert System - Newser
Did Incyte's (INCY) Leadership Shift and Pipeline Milestones Just Reshape Its Investment Narrative? - Yahoo Finance
Can technical indicators confirm Incyte Corporation’s reversalPortfolio Risk Summary & Expert Curated Trade Setup Alerts - Newser
How institutional ownership impacts Incyte Corporation stockJuly 2025 Chart Watch & Advanced Technical Analysis Signals - Newser
Will breakout in Incyte Corporation lead to full recoveryJuly 2025 Sector Moves & Community Consensus Trade Alerts - Newser
Detecting support and resistance levels for Incyte CorporationBull Run & Fast Exit/Entry Strategy Plans - Newser
Using R and stats models for Incyte Corporation forecastingJuly 2025 Drop Watch & Daily Profit Maximizing Trade Tips - Newser
Are Wall Street Analysts Predicting Incyte Stock Will Climb or Sink? - MSN
Finanzdaten der Incyte Corp-Aktie (INCY)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.33%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):